IRIS UniCatt

Valentini, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.138
EU - Europa 17.910
AS - Asia 7.740
SA - Sud America 831
AF - Africa 217
OC - Oceania 70
Continente sconosciuto - Info sul continente non disponibili 34
Totale 44.940
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.832
DE - Germania 5.698
SE - Svezia 3.798
SG - Singapore 2.756
CN - Cina 2.610
IT - Italia 2.177
UA - Ucraina 1.351
IE - Irlanda 1.028
FR - Francia 1.018
IN - India 844
BR - Brasile 733
ID - Indonesia 639
GB - Regno Unito 607
FI - Finlandia 510
RU - Federazione Russa 420
PL - Polonia 405
TR - Turchia 266
CA - Canada 239
BE - Belgio 201
CZ - Repubblica Ceca 136
AT - Austria 135
CI - Costa d'Avorio 128
NL - Olanda 119
HK - Hong Kong 100
JP - Giappone 93
IR - Iran 84
AU - Australia 55
CH - Svizzera 53
VN - Vietnam 49
ES - Italia 43
MX - Messico 35
LT - Lituania 28
PK - Pakistan 27
RO - Romania 27
IL - Israele 24
PE - Perù 24
PH - Filippine 24
AR - Argentina 23
EU - Europa 22
IQ - Iraq 21
MA - Marocco 21
AZ - Azerbaigian 20
KR - Corea 20
PT - Portogallo 19
CL - Cile 18
NO - Norvegia 18
EG - Egitto 17
GR - Grecia 16
PA - Panama 16
UZ - Uzbekistan 16
EC - Ecuador 15
NZ - Nuova Zelanda 15
BD - Bangladesh 14
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 13
AL - Albania 12
DK - Danimarca 12
KZ - Kazakistan 12
LK - Sri Lanka 12
AM - Armenia 11
KG - Kirghizistan 11
LV - Lettonia 11
ZA - Sudafrica 11
A2 - ???statistics.table.value.countryCode.A2??? 10
RS - Serbia 10
JO - Giordania 9
MY - Malesia 9
CO - Colombia 8
DZ - Algeria 8
KE - Kenya 8
LU - Lussemburgo 8
SK - Slovacchia (Repubblica Slovacca) 8
HR - Croazia 7
TH - Thailandia 7
TW - Taiwan 7
BG - Bulgaria 6
MD - Moldavia 6
TN - Tunisia 6
BO - Bolivia 5
EE - Estonia 5
HU - Ungheria 5
JM - Giamaica 5
BH - Bahrain 4
MT - Malta 4
NG - Nigeria 4
NP - Nepal 4
SC - Seychelles 4
BZ - Belize 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
VE - Venezuela 3
A1 - Anonimo 2
IS - Islanda 2
MK - Macedonia 2
MU - Mauritius 2
OM - Oman 2
SI - Slovenia 2
Totale 44.916
Salva come PNG Salva come JPEG
Città #
Chandler 4.048
Singapore 1.726
Ashburn 1.411
Dublin 1.023
Jacksonville 824
San Mateo 765
Ann Arbor 634
Jakarta 619
New York 539
Nanjing 515
Wilmington 515
Milan 460
Woodbridge 379
Warsaw 368
Boston 362
Dearborn 355
Hyderabad 348
The Dalles 328
Rome 324
Beijing 306
Princeton 293
Nürnberg 290
Moscow 284
Fairfield 274
Marseille 265
Houston 264
Los Angeles 251
Bremen 247
Lawrence 247
Cattolica 236
Helsinki 233
Izmir 218
Redwood City 203
Brussels 198
Seattle 190
Munich 185
Nanchang 180
Zhengzhou 160
Chicago 135
Frankfurt am Main 135
Boardman 129
Abidjan 128
Toronto 109
Shenyang 93
Leawood 92
Kunming 87
Vienna 87
Nuremberg 86
Norwalk 82
Hong Kong 79
Düsseldorf 77
Jiaxing 75
Hebei 74
Pune 74
Shanghai 74
Augusta 72
Tianjin 71
Cambridge 70
Mountain View 69
Brno 68
São Paulo 68
Changsha 66
Detroit 66
University Park 66
Washington 66
Fremont 65
Hangzhou 62
London 59
Guangzhou 58
Lauterbourg 56
North Bergen 55
Ottawa 53
Redmond 50
Falls Church 47
Lancaster 43
Phoenixville 43
North York 42
San Diego 42
Andover 40
Jinan 35
Falkenstein 34
Leesburg 34
Hefei 32
Columbus 30
Portsmouth 30
Paris 28
Simi Valley 28
Hanoi 27
Kish 27
Monmouth Junction 27
Tokyo 25
Amsterdam 24
Ningbo 24
Auburn Hills 23
Busto Arsizio 23
Phoenix 23
Zurich 23
Council Bluffs 22
Edinburgh 22
Lanzhou 22
Totale 23.643
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 805
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 317
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 258
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 254
Neoadjuvant Concurrent Radiochemotherapy in Locally Advanced (IIIa-IIIb) Non-Small Cell Lung Cancer: long term results according to downstaging. 251
The role of radiotherapy (RT) in the treatment of Adenoid Cystic Carcinoma of the Breast: case report of RT retreatment and literature review 237
EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy 231
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 226
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 222
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 212
Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials? 208
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population 204
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 202
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 197
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 182
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 178
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 177
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 172
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 171
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 171
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 170
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 170
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 169
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 169
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 167
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 160
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 153
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 151
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 151
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 151
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 150
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 149
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 149
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 148
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 148
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 147
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose. 146
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 145
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 145
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 144
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 144
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 144
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 142
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 142
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 141
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 140
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 140
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 139
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 138
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 138
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 136
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 136
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 135
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 135
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 134
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 133
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 132
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 131
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 131
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 131
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 131
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 131
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 131
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 131
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 130
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 129
Oncological outcome of hypopharyngeal carcinoma treated with different modalities at two different university hospitals 129
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 128
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 128
Multiple abscesses in a patient treated with cetuximab 126
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 126
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 124
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 124
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 124
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 124
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 124
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 123
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 123
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 121
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 120
Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer 119
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 119
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 119
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 117
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 117
Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma 116
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 116
Comparison of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ-preservation modalities in advanced laryngeal squamous cell carcinomas: A multicenter retrospective analysis 116
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 115
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 115
A real-time integrated framework to support clinical decision making for covid-19 patients 114
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 113
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 113
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 113
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 112
HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region 112
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 110
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 109
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 109
No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT) 108
Totale 15.508
Salva come PNG Salva come JPEG
Categoria #
all - tutte 222.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 222.316
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.037 0 0 0 0 0 0 0 0 0 0 674 363
2020/20213.396 204 381 108 377 505 152 342 79 371 213 550 114
2021/20225.302 519 308 103 415 253 171 80 728 235 351 1.140 999
2022/202311.308 1.579 1.551 877 1.763 675 1.323 571 880 1.260 241 415 173
2023/20245.583 231 1.530 224 369 241 865 324 300 79 192 581 647
2024/20257.810 314 362 890 433 1.135 421 416 537 1.695 1.282 325 0
Totale 46.145